product:testosterone

Sell a disease to sell a drug
▻http://www.washingtonpost.com/opinions/the-bulked-up-campaign-around-low-testosterone/2015/06/07/a9abda16-0573-11e5-8bda-c7b4e9a8f7ac_story.html

7 ans, des millions de dollars de profits et x victimes plus tard, la #FDA sort de sa torpeur

Seven years, at least 25 million prescriptions and $9.7 billion in sales too late, the Food and Drug Administration is finally pushing back against the over-prescribing of testosterone.

Last month, in response to new FDA rules, testosterone manufacturers released new instructions for doctors making it clear that testosterone is not approved for “low-T” — a marketing term developed by drug companies to describe men with low testosterone levels caused by aging. Companies must now warn doctors about a possible increased risk of heart attack and stroke in men who take these drugs.

#pharma

“Low T” and Prescription Testosterone : Public Viewing of the Science Does Matter - EveryONE
▻http://blogs.plos.org/everyone/2014/08/06/low-t-prescription-testosterone-public-viewing-science-matter

Sur l’inestimable valeur de l’"#open_access" pour la science.

... if we examine citations and post-publication commentary seven months since publication, the study has already accumulated 20 citations, more than any other article published in this timeframe. In addition to accumulating citations, the article has prompted researchers to call for additional, more definitive studies: an article published in The Lancet Diabetes and Endocrinology cited the PLOS ONE and JAMA articles and declared an urgent need for large clinical trials of testosterone. Last but not least, the article has stimulated significant post-publication commentary from readers who have analyzed and critiqued the methodology and characteristics of the cohort, spurring further discussion and research, and effectively moving post-publication peer review in a forward direction.

Therefore, the value of this article may not lie strictly in its views, shares, citations, or even saves, or any combination or calculation thereof, but instead in its open access visibility to the public, healthcare providers, federal agencies, and media outlets. Anyone, anywhere in the world with Internet access can read this article and its surrounding discussion and then decide for themselves how to respond and react, and that alone is worth more than any level of metrics combined.

Olympic Sex Verification - You Say You’re a Woman? That Should Be Enough - Rebecca Jordan-Young & Katrina Karkazis
►http://www.nytimes.com/2012/06/18/sports/olympics/olympic-sex-verification-you-say-youre-a-woman-that-should-be-enough.html

Unlike in doping cases, women with hyperandrogenism have not cheated. There is no reason to disqualify women whose bodies produce any of the complex ingredients that add up to athleticism, be they superb vision, big lungs, flexibility, long legs or testosterone.

The obsessive focus on sex has done enough harm.

#sport #sexe #ségrégation #mixte #JO

White American men in rural areas are the most likely to die during dumb macho stunts

►http://io9.com/5833035

White American men in rural areas are the most likely to die during dumb macho stunts

Are you a Caucasian male who lives in the countryside? If so, you’re America’s prime demographic to accidentally die during ill-advised, testosterone-fueled stupidity! These findings come courtesy of a recent study in Social Psychological and Personality Science ("Living Dangerously: Culture of Honor,
Risk-Taking, and the Nonrandomness of
‘Accidental’ Deaths") examined which demographic died the most frequently whilst defending their reputation with bird-brained acts of machismo. From the abstract:

une bonne nouvelle : la connerie tue ....